Stevanato Group (STVN)
NYSE:STVN
STVN Stock Chart & Stats
$13.62
-$0.46(-1.91%)
At close: 4:00 PM EST
$13.62
-$0.46(-1.91%)
Day’s Range― - ―
52-Week Range$13.55 - $28.00
Previous CloseN/A
Volume58.94K
Average Volume (3M)332.37K
Market Cap
$3.72B
Enterprise Value$3.56B
Total Cash (Recent Filing)$132.74M
Total Debt (Recent Filing)$470.70M
Price to Earnings (P/E)24.8
Beta0.69
Next Earnings
May 07, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield0.29%
Share Statistics
EPS (TTM)0.21
Shares Outstanding49,709,717
10 Day Avg. Volume278,451
30 Day Avg. Volume332,366
Financial Highlights & Ratios
PEG Ratio2.49
Price to Book (P/B)3.15
Price to Sales (P/S)4.10
P/FCF Ratio218.04
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue3.01
Enterprise Value/Gross Profit10.39
Enterprise Value/Ebitda12.61
Forecast
1Y Price Target
$24.50Price Target Upside79.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.61
Revenue Forecast (FY)$1.28B
Bulls Say, Bears Say
Bulls Say
BDS Segment GrowthStrong demand for high-value syringes and premium cartridges in the BDS segment is driving revenue momentum and supporting improved margins.
GLP-1 Exposure ClarityDisclosure that exposure to oral GLP products is smaller than feared reduces a major investor concern and lowers downside risk linked to that market.
Profitability OutperformanceReported results beat expectations across margins, operating profit measures, and earnings per share, signaling stronger-than-expected profitability.
Bears Say
Engineering Segment WeaknessOngoing underperformance in the Engineering segment, including shortfalls in glass conversion and device assembly, could pressure overall results and margins.
Guidance And Cash GenerationGuidance coming in slightly below expectations and inconsistent free cash generation may keep analyst sentiment neutral until execution stabilizes.
Sustainability Of New FormatsUncertainty about whether growth from new injectable formats can be sustained, due to early rollouts and limited contract visibility, raises execution risk.
Stevanato Group News
STVN FAQ
What was Stevanato Group’s price range in the past 12 months?
Stevanato Group lowest stock price was $13.55 and its highest was $28.00 in the past 12 months.
What is Stevanato Group’s market cap?
Stevanato Group’s market cap is $3.72B.
When is Stevanato Group’s upcoming earnings report date?
Stevanato Group’s upcoming earnings report date is May 07, 2026 which is in 40 days.
How were Stevanato Group’s earnings last quarter?
Stevanato Group released its earnings results on Mar 04, 2026. The company reported $0.209 earnings per share for the quarter, beating the consensus estimate of $0.195 by $0.014.
Is Stevanato Group overvalued?
According to Wall Street analysts Stevanato Group’s price is currently Undervalued.
Does Stevanato Group pay dividends?
Stevanato Group pays a Annually dividend of $0.061 which represents an annual dividend yield of 0.29%. See more information on Stevanato Group dividends here
What is Stevanato Group’s EPS estimate?
Stevanato Group’s EPS estimate is 0.12.
How many shares outstanding does Stevanato Group have?
Stevanato Group has 49,709,717 shares outstanding.
What happened to Stevanato Group’s price movement after its last earnings report?
Stevanato Group reported an EPS of $0.209 in its last earnings report, beating expectations of $0.195. Following the earnings report the stock price went up 18.805%.
Which hedge fund is a major shareholder of Stevanato Group?
Currently, no hedge funds are holding shares in STVN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Stevanato Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$24.50 (79.88% Upside)
$24.50 (79.88% Upside)
Blogger Sentiment
Bullish
STVN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 152.3K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.13%
12-Months-Change
Fundamentals
Return on Equity
9.72%
Trailing 12-Months
Asset Growth
23.90%
Trailing 12-Months
Company Description
Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
STVN Company Deck
STVN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution in high-value biopharmaceutical products, with meaningful revenue and margin expansion driven by BDS, high-value solutions and GLP-1 demand; operational investments (Latina, Fishers) and positive free cash flow support the growth strategy. Key challenges include a materially weaker Engineering segment (notably lower Q4 revenue and slower order conversion), FX/tariff headwinds, heavy near-term CapEx and some capacity ramp timing risk. On balance, the positive drivers (robust top-line growth, high-value mix, margin expansion, positive FCF, and constructive 2026 guidance) significantly outweigh the identified negatives.View all STVN earnings summariesSTVN Stock 12 Month Forecast
Average Price Target
$24.50
▲(79.88% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---